EMR
57
-5
ADBE
60
11
TSCO
49
3
OI
50
-4
LMT
50
13
K
54
4
TGNA
58
-3
COST
48
3
DGX
50
7
MRK
37
2
QRVO
68
-4
FSLR
73
-3
ECL
47
2
UHS
72
5
CAG
40
3
JNJ
56
5
VRSN
67
3
YUM
49
4
CAH
70
4
ROK
64
-2
EMR
57
-5
ADBE
60
11
TSCO
49
3
OI
50
-4
LMT
50
13
K
54
4
TGNA
58
-3
COST
48
3
DGX
50
7
MRK
37
2
QRVO
68
-4
FSLR
73
-3
ECL
47
2
UHS
72
5
CAG
40
3
JNJ
56
5
VRSN
67
3
YUM
49
4
CAH
70
4
ROK
64
-2
Financhill
Back

Repligen Stock Price Chart

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
36

RGEN
Repligen

Last Price:
$126.43
Seasonality Move:
4.98%

7 Day Trial

ALL ACCESS PASS

$ 7

Top investors are buying this "unlisted" stock

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGEN is experiencing selling pressure, which indicates risk of future bearish movement.

Repligen Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 128.12 Sell
20-day SMA: 134.88 Sell
50-day SMA: 135.37 Sell
200-day SMA: 145.89 Sell
8-day EMA: 129.21 Sell
20-day EMA: 131.87 Sell
50-day EMA: 136.15 Sell
200-day EMA: 145.7 Sell

Repligen Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.11 Sell
Relative Strength Index (14 RSI): 41.34 Sell
Chaikin Money Flow: -514328 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (125.07 - 140.65) Sell
Bollinger Bands (100): (131.35 - 159.97) Sell

Repligen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Repligen Stock

Is Repligen Stock a Buy?

  • Repligen share price is 123.26 while RGEN 8-day simple moving average is 128.12, which is a Sell signal.
  • The stock price of RGEN is 123.26 while Repligen 20-day SMA is 134.88, which makes it a Sell.
  • Repligen 50-day simple moving average is 135.37 while RGEN share price is 123.26, making it a Sell technically.
  • RGEN stock price is 123.26 and Repligen 200-day simple moving average is 145.89, creating a Sell signal.

RGEN Technical Analysis vs Fundamental Analysis

Sell
36
Repligen (RGEN) is a Sell

Is Repligen a Buy or a Sell?

  • Repligen stock is rated a Sell
    The current Repligen [RGEN] share price is $123.26. The Score for RGEN is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.

Repligen Stock Info

Market Cap:
6.9B
Price in USD:
123.26
Share Volume:
918.3K

Repligen 52-Week Range

52-Week High:
182.52
52-Week Low:
102.97
Sell
36
Repligen (RGEN) is a Sell

Repligen Share Price Forecast

  • What is the Repligen stock price today?
    The Repligen stock price is 123.26 USD today.
  • Will RGEN stock go up or go down?
    Repligen> share price is forecast to RISE/FALL based on technical indicators
  • Is Repligen overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, Repligen is overvalued.

Is Repligen Stock a Buy?

  • Repligen share price is 123.26 while RGEN 8-day exponential moving average is 129.21, which is a Sell signal.
  • The stock price of RGEN is 123.26 while Repligen 20-day EMA is 131.87, which makes it a Sell.
  • Repligen 50-day exponential moving average is 136.15 while RGEN share price is 123.26, making it a Sell technically.
  • RGEN stock price is 123.26 and Repligen 200-day simple moving average is 145.70, creating a Sell signal.

Fundamental Analysis of Repligen

Is Repligen a good investment?

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.14 per share, an increase this year of $0.14 per share, and an increase next year of $0.49 per share.

Technical Analysis of Repligen

Should I short Repligen stock?

  • RGEN Moving Average Covergence Divergence (MACD) indicator is -2.11, suggesting Repligen is a Sell
  • Repligen Relative Strength Index (RSI) is 41.34, which suggest Repligen is oversold
  • The Bollinger Bands (25) for Repligen is (125.07 - 140.65), which suggest Repligen is a Sell
  • The Bollinger Bands (100) for Repligen is (131.35 - 159.97), which suggest Repligen is a Sell

* Repligen stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.